JAMES ORR was appointed chair of the Florida Board of Medicine. Orr is medical director of Florida Gynecologic Oncology, a division of 21st Century Oncology. He will direct the actions of the board that oversees 68,000 Florida physicians.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
